SIMILAR PATTERNS OF AMINO ACIDS FOR 4P65_C_IPHC101
List of similar pattern of amino acids derived from ASSAM searchHit | Macromolecule/ Organism |
Pfam | Res. | Interface | HETATM | RMSD | Dali Z-score | Seq. Identity (%) | View | Dock | |
---|---|---|---|---|---|---|---|---|---|---|---|
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1a27 | 17-BETA-HYDROXYSTEROID-DEHYDROGENASE (Homo sapiens) |
PF00106(adh_short) | 5 | CYH A 166LEU A 165ALA A 161VAL A 139LEU A 182 | None | 0.97A | 4p65C-1a27A:undetectable4p65D-1a27A:undetectable4p65J-1a27A:undetectable4p65L-1a27A:undetectable | 4p65C-1a27A:5.424p65D-1a27A:7.174p65J-1a27A:7.174p65L-1a27A:7.17 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1f6f | PLACENTAL LACTOGEN (Ovis aries) |
PF00103(Hormone_1) | 5 | LEU A 172HIS A 98LEU A 97ALA A 100LEU A 157 | None | 1.03A | 4p65C-1f6fA:undetectable4p65D-1f6fA:undetectable4p65J-1f6fA:undetectable4p65L-1f6fA:undetectable | 4p65C-1f6fA:10.424p65D-1f6fA:12.364p65J-1f6fA:12.364p65L-1f6fA:12.36 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1fdw | 17-BETA-HYDROXYSTEROID DEHYDROGENASE (Homo sapiens) |
PF00106(adh_short) | 5 | CYH A 166LEU A 165ALA A 161VAL A 139LEU A 182 | None | 0.97A | 4p65C-1fdwA:undetectable4p65D-1fdwA:undetectable4p65J-1fdwA:undetectable4p65L-1fdwA:undetectable | 4p65C-1fdwA:5.664p65D-1fdwA:6.774p65J-1fdwA:6.774p65L-1fdwA:6.77 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1gzk | RAC-BETASERINE/THREONINEPROTEIN KINASE (Homo sapiens) |
PF00069(Pkinase)PF00433(Pkinase_C) | 5 | CYH A 345LEU A 381LEU A 373ALA A 377VAL A 246 | None | 1.04A | 4p65C-1gzkA:undetectable4p65D-1gzkA:undetectable4p65J-1gzkA:undetectable4p65L-1gzkA:undetectable | 4p65C-1gzkA:7.944p65D-1gzkA:10.134p65J-1gzkA:10.134p65L-1gzkA:10.13 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1i7k | UBIQUITIN-CONJUGATING ENZYME E2 H10 (Homo sapiens) |
PF00179(UQ_con) | 5 | LEU A 132LEU A 83ALA A 52LEU A 42LEU A 35 | None | 0.97A | 4p65C-1i7kA:undetectable4p65D-1i7kA:undetectable4p65J-1i7kA:undetectable4p65L-1i7kA:undetectable | 4p65C-1i7kA:8.064p65D-1i7kA:9.474p65J-1i7kA:9.474p65L-1i7kA:9.47 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1j33 | COBT (Thermusthermophilus) |
PF02277(DBI_PRT) | 5 | LEU A 290LEU A 259ALA A 258LEU A 249HIS A 283 | None | 1.07A | 4p65C-1j33A:undetectable4p65D-1j33A:undetectable4p65J-1j33A:undetectable4p65L-1j33A:undetectable | 4p65C-1j33A:5.834p65D-1j33A:5.524p65J-1j33A:5.524p65L-1j33A:5.52 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1jed | SULFATEADENYLYLTRANSFERASE (Saccharomycescerevisiae) |
PF01747(ATP-sulfurylase)PF14306(PUA_2) | 5 | LEU A 158LEU A 104ALA A 113LEU A 49LEU A 42 | None | 1.09A | 4p65C-1jedA:undetectable4p65D-1jedA:undetectable4p65J-1jedA:undetectable4p65L-1jedA:undetectable | 4p65C-1jedA:3.004p65D-1jedA:7.014p65J-1jedA:7.014p65L-1jedA:7.01 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1knb | ADENOVIRUS TYPE 5FIBER PROTEIN (HumanmastadenovirusC) |
PF00541(Adeno_knob) | 5 | LEU A 413LEU A 445ALA A 440VAL A 530LEU A 522 | None | 1.16A | 4p65C-1knbA:undetectable4p65D-1knbA:undetectable4p65J-1knbA:undetectable4p65L-1knbA:undetectable | 4p65C-1knbA:6.704p65D-1knbA:10.224p65J-1knbA:10.224p65L-1knbA:10.22 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1luf | MUSCLE-SPECIFICTYROSINE KINASERECEPTOR MUSK (Rattusnorvegicus) |
PF07714(Pkinase_Tyr) | 5 | LEU A 855CYH A 698LEU A 702ALA A 705LEU A 791 | None | 0.99A | 4p65C-1lufA:undetectable4p65D-1lufA:undetectable4p65J-1lufA:undetectable4p65L-1lufA:undetectable | 4p65C-1lufA:4.474p65D-1lufA:6.344p65J-1lufA:6.344p65L-1lufA:6.34 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1n7j | PHENYLETHANOLAMINEN-METHYLTRANSFERASE (Homo sapiens) |
PF01234(NNMT_PNMT_TEMT) | 5 | LEU A 243LEU A 213ALA A 275LEU A 253VAL A 234 | None | 1.10A | 4p65C-1n7jA:undetectable4p65D-1n7jA:undetectable4p65J-1n7jA:undetectable4p65L-1n7jA:undetectable | 4p65C-1n7jA:20.754p65D-1n7jA:8.034p65J-1n7jA:8.034p65L-1n7jA:8.03 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1re5 | 3-CARBOXY-CIS,CIS-MUCONATECYCLOISOMERASE (Pseudomonasputida) |
PF00206(Lyase_1)PF10397(ADSL_C) | 5 | LEU A 173LEU A 129LEU A 247VAL A 239LEU A 240 | None | 1.14A | 4p65C-1re5A:undetectable4p65D-1re5A:undetectable4p65J-1re5A:undetectable4p65L-1re5A:undetectable | 4p65C-1re5A:3.994p65D-1re5A:5.124p65J-1re5A:5.124p65L-1re5A:5.12 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1tqy | ACTINORHODINPOLYKETIDE PUTATIVEBETA-KETOACYLSYNTHASE 2 (Streptomycescoelicolor) |
PF00109(ketoacyl-synt)PF02801(Ketoacyl-synt_C) | 5 | LEU B 165LEU B 168ALA B 398VAL B 343LEU B 346 | None | 1.11A | 4p65C-1tqyB:undetectable4p65D-1tqyB:undetectable4p65J-1tqyB:undetectable4p65L-1tqyB:undetectable | 4p65C-1tqyB:5.474p65D-1tqyB:8.844p65J-1tqyB:8.844p65L-1tqyB:8.84 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1ttw | SECRETION CHAPERONE (Yersinia pestis) |
PF05932(CesT) | 5 | CYH A 81LEU A 91LEU A 119ALA A 54LEU A 57 | None | 0.95A | 4p65C-1ttwA:undetectable4p65D-1ttwA:undetectable4p65J-1ttwA:undetectable4p65L-1ttwA:undetectable | 4p65C-1ttwA:9.354p65D-1ttwA:15.054p65J-1ttwA:15.054p65L-1ttwA:15.05 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1wlj | INTERFERONSTIMULATED GENE20KDA (Homo sapiens) |
PF00929(RNase_T) | 5 | CYH A 28LEU A 25LEU A 98ALA A 97LEU A 91 | None | 1.14A | 4p65C-1wljA:undetectable4p65D-1wljA:undetectable4p65J-1wljA:undetectable4p65L-1wljA:undetectable | 4p65C-1wljA:7.844p65D-1wljA:11.394p65J-1wljA:11.394p65L-1wljA:11.39 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1xm9 | PLAKOPHILIN 1 (Homo sapiens) |
PF00514(Arm) | 5 | LEU A 296LEU A 311ALA A 308LEU A 350LEU A 357 | None | 1.12A | 4p65C-1xm9A:undetectable4p65D-1xm9A:undetectable4p65J-1xm9A:undetectable4p65L-1xm9A:undetectable | 4p65C-1xm9A:3.864p65D-1xm9A:6.674p65J-1xm9A:6.674p65L-1xm9A:6.67 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2b8e | CATION-TRANSPORTINGATPASE (Archaeoglobusfulgidus) |
PF00702(Hydrolase) | 5 | LEU A 429LEU A 655ALA A 554LEU A 586VAL A 421 | None | 1.12A | 4p65C-2b8eA:undetectable4p65D-2b8eA:undetectable4p65J-2b8eA:undetectable4p65L-2b8eA:undetectable | 4p65C-2b8eA:8.704p65D-2b8eA:8.134p65J-2b8eA:8.134p65L-2b8eA:8.13 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2b8e | CATION-TRANSPORTINGATPASE (Archaeoglobusfulgidus) |
PF00702(Hydrolase) | 5 | LEU A 655ALA A 554LEU A 586VAL A 421LEU A 561 | None | 0.96A | 4p65C-2b8eA:undetectable4p65D-2b8eA:undetectable4p65J-2b8eA:undetectable4p65L-2b8eA:undetectable | 4p65C-2b8eA:8.704p65D-2b8eA:8.134p65J-2b8eA:8.134p65L-2b8eA:8.13 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2d96 | NUCLEAR FACTORNF-KAPPA-B P100SUBUNIT (Homo sapiens) |
PF00531(Death) | 5 | LEU A 36LEU A 77ALA A 76LEU A 40LEU A 70 | None | 1.03A | 4p65C-2d96A:undetectable4p65D-2d96A:undetectable4p65J-2d96A:undetectable4p65L-2d96A:undetectable | 4p65C-2d96A:9.174p65D-2d96A:15.844p65J-2d96A:15.844p65L-2d96A:15.84 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2dul | N(2),N(2)-DIMETHYLGUANOSINE TRNAMETHYLTRANSFERASE (Pyrococcushorikoshii) |
PF02005(TRM) | 5 | LEU A 233LEU A 151ALA A 154VAL A 162LEU A 137 | None | 0.87A | 4p65C-2dulA:undetectable4p65D-2dulA:undetectable4p65J-2dulA:undetectable4p65L-2dulA:undetectable | 4p65C-2dulA:4.184p65D-2dulA:6.124p65J-2dulA:6.124p65L-2dulA:6.12 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2e2c | UBIQUITINCONJUGATING ENZYME (Spisulasolidissima) |
PF00179(UQ_con) | 5 | LEU A 132LEU A 83ALA A 52LEU A 42LEU A 35 | None | 1.03A | 4p65C-2e2cA:undetectable4p65D-2e2cA:undetectable4p65J-2e2cA:undetectable4p65L-2e2cA:undetectable | 4p65C-2e2cA:9.684p65D-2e2cA:9.154p65J-2e2cA:9.154p65L-2e2cA:9.15 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2efj | 3,7-DIMETHYLXANTHINEMETHYLTRANSFERASE (Coffeacanephora) |
PF03492(Methyltransf_7) | 5 | LEU A 47CYH A 38LEU A 42ALA A 45LEU A 287 | None | 1.06A | 4p65C-2efjA:undetectable4p65D-2efjA:undetectable4p65J-2efjA:undetectable4p65L-2efjA:undetectable | 4p65C-2efjA:6.364p65D-2efjA:6.164p65J-2efjA:6.164p65L-2efjA:6.16 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2ffh | PROTEIN (FFH) (Thermusaquaticus) |
PF00448(SRP54)PF02881(SRP54_N)PF02978(SRP_SPB) | 5 | LEU A 257LEU A 5LEU A 86VAL A 78LEU A 292 | None | 1.12A | 4p65C-2ffhA:undetectable4p65D-2ffhA:undetectable4p65J-2ffhA:undetectable4p65L-2ffhA:undetectable | 4p65C-2ffhA:4.724p65D-2ffhA:6.364p65J-2ffhA:6.364p65L-2ffhA:6.36 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2g8l | 287AA LONGHYPOTHETICAL PROTEIN (Pyrococcushorikoshii) |
PF01937(DUF89) | 5 | LEU A 167CYH A 280LEU A 259ALA A 104LEU A 133 | None | 1.12A | 4p65C-2g8lA:undetectable4p65D-2g8lA:undetectable4p65J-2g8lA:undetectable4p65L-2g8lA:undetectable | 4p65C-2g8lA:4.424p65D-2g8lA:7.174p65J-2g8lA:7.174p65L-2g8lA:7.17 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2gnw | NON-SYMBIOTICHEMOGLOBIN 1 (Oryza sativa) |
PF00042(Globin) | 5 | LEU A 101HIS A 152LEU A 153ALA A 156LEU A 88 | NoneNoneHEM A 166 ( 4.7A)NoneNone | 1.08A | 4p65C-2gnwA:undetectable4p65D-2gnwA:undetectable4p65J-2gnwA:undetectable4p65L-2gnwA:undetectable | 4p65C-2gnwA:5.454p65D-2gnwA:9.704p65J-2gnwA:9.704p65L-2gnwA:9.70 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2lxp | UBIQUITIN-CONJUGATING ENZYME E2 G2 (Homo sapiens) |
PF00179(UQ_con) | 5 | LEU A 120LEU A 58ALA A 26LEU A 16LEU A 9 | None | 0.95A | 4p65C-2lxpA:undetectable4p65D-2lxpA:undetectable4p65J-2lxpA:undetectable4p65L-2lxpA:undetectable | 4p65C-2lxpA:11.304p65D-2lxpA:12.304p65J-2lxpA:12.304p65L-2lxpA:12.30 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2ng1 | SIGNAL SEQUENCERECOGNITION PROTEINFFH (Thermusaquaticus) |
PF00448(SRP54)PF02881(SRP54_N) | 5 | LEU A 257LEU A 5LEU A 86VAL A 78LEU A 292 | None | 1.11A | 4p65C-2ng1A:undetectable4p65D-2ng1A:undetectable4p65J-2ng1A:undetectable4p65L-2ng1A:undetectable | 4p65C-2ng1A:5.154p65D-2ng1A:7.644p65J-2ng1A:7.644p65L-2ng1A:7.64 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2q0f | RNA URIDYLYLTRANSFERASE (Trypanosomabrucei) |
PF03828(PAP_assoc) | 5 | HIS A 320LEU A 321ALA A 324LEU A 329LEU A 177 | None | 1.04A | 4p65C-2q0fA:undetectable4p65D-2q0fA:undetectable4p65J-2q0fA:undetectable4p65L-2q0fA:undetectable | 4p65C-2q0fA:5.484p65D-2q0fA:6.344p65J-2q0fA:6.344p65L-2q0fA:6.34 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2q0f | RNA URIDYLYLTRANSFERASE (Trypanosomabrucei) |
PF03828(PAP_assoc) | 5 | LEU A 245HIS A 320ALA A 324LEU A 329LEU A 177 | None | 1.13A | 4p65C-2q0fA:undetectable4p65D-2q0fA:undetectable4p65J-2q0fA:undetectable4p65L-2q0fA:undetectable | 4p65C-2q0fA:5.484p65D-2q0fA:6.344p65J-2q0fA:6.344p65L-2q0fA:6.34 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2r1h | HEMOGLOBIN SUBUNITALPHA-4 (Oncorhynchusmykiss) |
PF00042(Globin) | 5 | CYH A 70LEU A 81LEU A 133ALA A 136LEU A 2 | None | 1.05A | 4p65C-2r1hA:undetectable4p65D-2r1hA:undetectable4p65J-2r1hA:undetectable4p65L-2r1hA:undetectable | 4p65C-2r1hA:10.944p65D-2r1hA:22.084p65J-2r1hA:22.084p65L-2r1hA:22.08 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2rg4 | UNCHARACTERIZEDPROTEIN (Oceanicolagranulosus) |
PF13759(2OG-FeII_Oxy_5) | 5 | LEU A 76LEU A 19VAL A 84HIS A 83LEU A 180 | None | 0.97A | 4p65C-2rg4A:undetectable4p65D-2rg4A:undetectable4p65J-2rg4A:undetectable4p65L-2rg4A:undetectable | 4p65C-2rg4A:7.574p65D-2rg4A:10.984p65J-2rg4A:10.984p65L-2rg4A:10.98 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2voy | CATION-TRANSPORTINGATPASE (Archaeoglobusfulgidus) |
PF00702(Hydrolase) | 5 | LEU I 429LEU I 655ALA I 554LEU I 586VAL I 421 | None | 1.12A | 4p65C-2voyI:undetectable4p65D-2voyI:undetectable4p65J-2voyI:undetectable4p65L-2voyI:undetectable | 4p65C-2voyI:9.894p65D-2voyI:15.154p65J-2voyI:15.154p65L-2voyI:15.15 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2voy | CATION-TRANSPORTINGATPASE (Archaeoglobusfulgidus) |
PF00702(Hydrolase) | 5 | LEU I 655ALA I 554LEU I 586VAL I 421LEU I 561 | None | 0.96A | 4p65C-2voyI:undetectable4p65D-2voyI:undetectable4p65J-2voyI:undetectable4p65L-2voyI:undetectable | 4p65C-2voyI:9.894p65D-2voyI:15.154p65J-2voyI:15.154p65L-2voyI:15.15 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2x8u | SERINEPALMITOYLTRANSFERASE (Sphingomonaswittichii) |
PF00155(Aminotran_1_2) | 5 | LEU A 373HIS A 310LEU A 309VAL A 332LEU A 320 | None | 1.05A | 4p65C-2x8uA:undetectable4p65D-2x8uA:undetectable4p65J-2x8uA:undetectable4p65L-2x8uA:undetectable | 4p65C-2x8uA:12.044p65D-2x8uA:6.764p65J-2x8uA:6.764p65L-2x8uA:6.76 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2yzm | D-ALANINE--D-ALANINELIGASE (Thermusthermophilus) |
PF01820(Dala_Dala_lig_N)PF07478(Dala_Dala_lig_C) | 5 | LEU A 69ALA A 35LEU A 4VAL A 91LEU A 81 | None | 1.16A | 4p65C-2yzmA:undetectable4p65D-2yzmA:undetectable4p65J-2yzmA:undetectable4p65L-2yzmA:undetectable | 4p65C-2yzmA:4.384p65D-2yzmA:7.214p65J-2yzmA:7.214p65L-2yzmA:7.21 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3bvc | UNCHARACTERIZEDPROTEIN ISM_01780 (Roseovariusnubinhibens) |
PF13759(2OG-FeII_Oxy_5) | 5 | LEU A 76LEU A 19VAL A 84HIS A 83LEU A 180 | None | 1.03A | 4p65C-3bvcA:undetectable4p65D-3bvcA:undetectable4p65J-3bvcA:undetectable4p65L-3bvcA:undetectable | 4p65C-3bvcA:7.574p65D-3bvcA:10.244p65J-3bvcA:10.244p65L-3bvcA:10.24 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3cit | SENSOR HISTIDINEKINASE (Pseudomonassyringae groupgenomosp. 3) |
no annotation | 5 | LEU A 131LEU A 51ALA A 54LEU A 148LEU A 155 | None | 0.92A | 4p65C-3citA:undetectable4p65D-3citA:undetectable4p65J-3citA:undetectable4p65L-3citA:undetectable | 4p65C-3citA:11.904p65D-3citA:14.414p65J-3citA:14.414p65L-3citA:14.41 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3e7w | D-ALANINE--POLY(PHOSPHORIBITOL) LIGASESUBUNIT 1 (Bacillussubtilis) |
PF00501(AMP-binding)PF13193(AMP-binding_C) | 5 | LEU A 206CYH A 214LEU A 212ALA A 19LEU A 32 | None | 1.08A | 4p65C-3e7wA:undetectable4p65D-3e7wA:undetectable4p65J-3e7wA:undetectable4p65L-3e7wA:undetectable | 4p65C-3e7wA:3.914p65D-3e7wA:7.974p65J-3e7wA:7.974p65L-3e7wA:7.97 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3ef1 | RNA POLYMERASE IISUBUNIT A C-TERMINALDOMAIN PHOSPHATASE (Schizosaccharomycespombe) |
PF03031(NIF)PF12738(PTCB-BRCT) | 5 | LEU A 491LEU A 496ALA A 517LEU A 566VAL A 557 | None | 1.10A | 4p65C-3ef1A:undetectable4p65D-3ef1A:undetectable4p65J-3ef1A:undetectable4p65L-3ef1A:undetectable | 4p65C-3ef1A:6.284p65D-3ef1A:4.564p65J-3ef1A:4.564p65L-3ef1A:4.56 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3g8m | SERINEHYDROXYMETHYLTRANSFERASE (Escherichiacoli) |
PF00464(SHMT) | 5 | LEU A 390LEU A 337ALA A 333LEU A 323VAL A 364 | None | 1.02A | 4p65C-3g8mA:undetectable4p65D-3g8mA:undetectable4p65J-3g8mA:undetectable4p65L-3g8mA:undetectable | 4p65C-3g8mA:4.904p65D-3g8mA:6.494p65J-3g8mA:6.494p65L-3g8mA:6.49 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3gdj | HEMOGLOBIN SUBUNITBETA (Camelusdromedarius) |
PF00042(Globin) | 5 | LEU B 126HIS B 12LEU B 14ALA B 10LEU B 75 | None | 1.14A | 4p65C-3gdjB:undetectable4p65D-3gdjB:undetectable4p65J-3gdjB:undetectable4p65L-3gdjB:undetectable | 4p65C-3gdjB:5.634p65D-3gdjB:12.264p65J-3gdjB:12.264p65L-3gdjB:12.26 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3hhr | HUMAN GROWTH HORMONE (Homo sapiens) |
PF00103(Hormone_1) | 5 | LEU A 117HIS A 21LEU A 20ALA A 17LEU A 177 | None | 1.12A | 4p65C-3hhrA:undetectable4p65D-3hhrA:undetectable4p65J-3hhrA:undetectable4p65L-3hhrA:undetectable | 4p65C-3hhrA:7.894p65D-3hhrA:10.294p65J-3hhrA:10.294p65L-3hhrA:10.29 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3i9v | NADH-QUINONEOXIDOREDUCTASESUBUNIT 3 (Thermusthermophilus) |
PF00384(Molybdopterin)PF01568(Molydop_binding)PF04879(Molybdop_Fe4S4)PF10588(NADH-G_4Fe-4S_3)PF13510(Fer2_4) | 5 | LEU 3 641LEU 3 360ALA 3 357LEU 3 345VAL 3 341 | None | 1.09A | 4p65C-3i9v3:undetectable4p65D-3i9v3:undetectable4p65J-3i9v3:undetectable4p65L-3i9v3:undetectable | 4p65C-3i9v3:2.444p65D-3i9v3:3.604p65J-3i9v3:3.604p65L-3i9v3:3.60 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3igh | UNCHARACTERIZEDMETAL-DEPENDENTHYDROLASE (Pyrococcushorikoshii) |
PF07969(Amidohydro_3) | 5 | LEU X 285ALA X 290LEU X 292VAL X 359LEU X 337 | None | 1.13A | 4p65C-3ighX:undetectable4p65D-3ighX:undetectable4p65J-3ighX:undetectable4p65L-3ighX:undetectable | 4p65C-3ighX:4.644p65D-3ighX:6.054p65J-3ighX:6.054p65L-3ighX:6.05 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3mdy | BONE MORPHOGENETICPROTEIN RECEPTORTYPE-1B (Homo sapiens) |
PF07714(Pkinase_Tyr)PF08515(TGF_beta_GS) | 5 | LEU A 491LEU A 302ALA A 305LEU A 407LEU A 463 | None | 1.07A | 4p65C-3mdyA:undetectable4p65D-3mdyA:undetectable4p65J-3mdyA:undetectable4p65L-3mdyA:undetectable | 4p65C-3mdyA:5.654p65D-3mdyA:5.974p65J-3mdyA:5.974p65L-3mdyA:5.97 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3ngw | MOLYBDOPTERIN-GUANINE DINUCLEOTIDEBIOSYNTHESIS PROTEINA (MOBA) (Archaeoglobusfulgidus) |
PF12804(NTP_transf_3) | 5 | LEU A 138CYH A 86LEU A 80ALA A 134VAL A 88 | None | 1.16A | 4p65C-3ngwA:undetectable4p65D-3ngwA:undetectable4p65J-3ngwA:undetectable4p65L-3ngwA:undetectable | 4p65C-3ngwA:16.134p65D-3ngwA:12.904p65J-3ngwA:12.904p65L-3ngwA:12.90 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3no3 | GLYCEROPHOSPHODIESTER PHOSPHODIESTERASE (Parabacteroidesdistasonis) |
PF03009(GDPD) | 5 | LEU A 120LEU A 109ALA A 112LEU A 47VAL A 62 | None | 1.06A | 4p65C-3no3A:undetectable4p65D-3no3A:undetectable4p65J-3no3A:undetectable4p65L-3no3A:undetectable | 4p65C-3no3A:8.184p65D-3no3A:7.984p65J-3no3A:7.984p65L-3no3A:7.98 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3og9 | PROTEIN YAHD ACOPPER INDUCIBLEHYDROLASE (Lactococcuslactis) |
PF01738(DLH) | 5 | LEU A 114HIS A 131ALA A 129LEU A 151VAL A 160 | None | 1.07A | 4p65C-3og9A:undetectable4p65D-3og9A:undetectable4p65J-3og9A:undetectable4p65L-3og9A:undetectable | 4p65C-3og9A:5.774p65D-3og9A:9.604p65J-3og9A:9.604p65L-3og9A:9.60 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3p0w | MANDELATERACEMASE/MUCONATELACTONIZING PROTEIN (Ralstoniapickettii) |
PF13378(MR_MLE_C) | 5 | LEU A 136ALA A 135LEU A 43VAL A 68LEU A 65 | None | 1.15A | 4p65C-3p0wA:undetectable4p65D-3p0wA:undetectable4p65J-3p0wA:undetectable4p65L-3p0wA:undetectable | 4p65C-3p0wA:4.034p65D-3p0wA:11.324p65J-3p0wA:11.324p65L-3p0wA:11.32 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3pdi | NITROGENASE MOFECOFACTORBIOSYNTHESIS PROTEINNIFN (Azotobactervinelandii) |
PF00148(Oxidored_nitro) | 5 | LEU B 332ALA B 314LEU B 431VAL B 423LEU B 424 | None | 0.91A | 4p65C-3pdiB:undetectable4p65D-3pdiB:undetectable4p65J-3pdiB:undetectable4p65L-3pdiB:undetectable | 4p65C-3pdiB:7.614p65D-3pdiB:6.504p65J-3pdiB:6.504p65L-3pdiB:6.50 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3sdi | PROTEASOME COMPONENTPRE5 (Saccharomycescerevisiae) |
PF00227(Proteasome)PF10584(Proteasome_A_N) | 5 | CYH E 70LEU E 92ALA E 112LEU E 107HIS E 73 | None | 0.94A | 4p65C-3sdiE:undetectable4p65D-3sdiE:undetectable4p65J-3sdiE:undetectable4p65L-3sdiE:undetectable | 4p65C-3sdiE:13.954p65D-3sdiE:9.914p65J-3sdiE:9.914p65L-3sdiE:9.91 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3slk | POLYKETIDE SYNTHASEEXTENDER MODULE 2 (Saccharopolysporaspinosa) |
PF08240(ADH_N)PF08659(KR)PF13602(ADH_zinc_N_2) | 5 | LEU A 13ALA A 149LEU A 163VAL A 136LEU A 97 | None | 1.07A | 4p65C-3slkA:undetectable4p65D-3slkA:undetectable4p65J-3slkA:undetectable4p65L-3slkA:undetectable | 4p65C-3slkA:2.264p65D-3slkA:3.664p65J-3slkA:3.664p65L-3slkA:3.66 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3tz6 | ASPARTATE-SEMIALDEHYDE DEHYDROGENASE (Mycobacteriumtuberculosis) |
PF01118(Semialdhyde_dh)PF02774(Semialdhyde_dhC) | 5 | LEU A 142LEU A 277ALA A 273LEU A 317VAL A 321 | None | 1.02A | 4p65C-3tz6A:undetectable4p65D-3tz6A:undetectable4p65J-3tz6A:undetectable4p65L-3tz6A:undetectable | 4p65C-3tz6A:6.544p65D-3tz6A:7.474p65J-3tz6A:7.474p65L-3tz6A:7.47 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3uet | ALPHA-1,3/4-FUCOSIDASE (Bifidobacteriumlongum) |
PF01120(Alpha_L_fucos) | 5 | LEU A 373ALA A 473LEU A 395VAL A 461LEU A 421 | None | 1.10A | 4p65C-3uetA:undetectable4p65D-3uetA:undetectable4p65J-3uetA:undetectable4p65L-3uetA:undetectable | 4p65C-3uetA:4.324p65D-3uetA:4.064p65J-3uetA:4.064p65L-3uetA:4.06 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3wqf | D-THREO-3-HYDROXYASPARTATE DEHYDRATASE (Delftia sp.HT23) |
PF01168(Ala_racemase_N)PF14031(D-ser_dehydrat) | 5 | LEU A 67CYH A 103LEU A 98ALA A 95LEU A 107 | None | 1.10A | 4p65C-3wqfA:undetectable4p65D-3wqfA:undetectable4p65J-3wqfA:undetectable4p65L-3wqfA:undetectable | 4p65C-3wqfA:3.854p65D-3wqfA:7.694p65J-3wqfA:7.694p65L-3wqfA:7.69 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4dkb | DEOXYURIDINETRIPHOSPHATASE (Trypanosomabrucei) |
PF08761(dUTPase_2) | 6 | LEU A 238HIS A 209LEU A 211ALA A 207HIS A 82LEU A 24 | NoneNoneNoneNoneDUN A 303 (-3.7A)DUN A 303 (-4.3A) | 1.40A | 4p65C-4dkbA:undetectable4p65D-4dkbA:undetectable4p65J-4dkbA:undetectable4p65L-4dkbA:undetectable | 4p65C-4dkbA:5.044p65D-4dkbA:7.534p65J-4dkbA:7.534p65L-4dkbA:7.53 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4g3a | CLIP-ASSOCIATINGPROTEIN (Drosophilamelanogaster) |
PF12348(CLASP_N) | 5 | LEU A 31LEU A 35ALA A 72LEU A 54LEU A 80 | None | 1.10A | 4p65C-4g3aA:undetectable4p65D-4g3aA:undetectable4p65J-4g3aA:undetectable4p65L-4g3aA:undetectable | 4p65C-4g3aA:7.984p65D-4g3aA:9.274p65J-4g3aA:9.274p65L-4g3aA:9.27 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4g8z | DIHYDROFOLATEREDUCTASE (Pneumocystisjirovecii) |
PF00186(DHFR_1) | 5 | LEU X 98LEU X 7ALA X 132LEU X 128VAL X 54 | NoneNoneNoneNDP X 302 (-4.0A)None | 1.15A | 4p65C-4g8zX:undetectable4p65D-4g8zX:undetectable4p65J-4g8zX:undetectable4p65L-4g8zX:undetectable | 4p65C-4g8zX:7.414p65D-4g8zX:10.304p65J-4g8zX:10.304p65L-4g8zX:10.30 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4h05 | AMINOGLYCOSIDE-O-PHOSPHOTRANSFERASE VIII (Streptomycesrimosus) |
PF01636(APH) | 5 | LEU A 202LEU A 62LEU A 113VAL A 180LEU A 120 | None | 1.14A | 4p65C-4h05A:undetectable4p65D-4h05A:undetectable4p65J-4h05A:undetectable4p65L-4h05A:undetectable | 4p65C-4h05A:4.954p65D-4h05A:8.444p65J-4h05A:8.444p65L-4h05A:8.44 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4ivn | TRANSCRIPTIONALREGULATOR (Vibriovulnificus) |
PF01380(SIS)PF01418(HTH_6) | 5 | LEU A 8LEU A 30ALA A 33LEU A 74LEU A 58 | None | 1.14A | 4p65C-4ivnA:undetectable4p65D-4ivnA:undetectable4p65J-4ivnA:undetectable4p65L-4ivnA:undetectable | 4p65C-4ivnA:5.784p65D-4ivnA:8.054p65J-4ivnA:8.054p65L-4ivnA:8.05 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4kng | E3 UBIQUITIN-PROTEINLIGASE RNF43 (Homo sapiens) |
no annotation | 5 | LEU E 122LEU E 151ALA E 147LEU E 109VAL E 137 | None | 1.16A | 4p65C-4kngE:undetectable4p65D-4kngE:undetectable4p65J-4kngE:undetectable4p65L-4kngE:undetectable | 4p65C-4kngE:10.144p65D-4kngE:11.254p65J-4kngE:11.254p65L-4kngE:11.25 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4m5d | RIBOSOMALRNA-PROCESSINGPROTEIN 7 (Saccharomycescerevisiae) |
PF12923(RRP7) | 5 | LEU B 55CYH B 137ALA B 39VAL B 71LEU B 74 | None | 1.16A | 4p65C-4m5dB:undetectable4p65D-4m5dB:undetectable4p65J-4m5dB:undetectable4p65L-4m5dB:undetectable | 4p65C-4m5dB:5.414p65D-4m5dB:8.734p65J-4m5dB:8.734p65L-4m5dB:8.73 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4mni | TRAP DICARBOXYLATETRANSPORTER-DCTPSUBUNIT (Polaromonas sp.JS666) |
PF03480(DctP) | 5 | LEU A 235LEU A 34LEU A 260VAL A 45LEU A 49 | None | 1.11A | 4p65C-4mniA:undetectable4p65D-4mniA:undetectable4p65J-4mniA:undetectable4p65L-4mniA:undetectable | 4p65C-4mniA:6.494p65D-4mniA:5.694p65J-4mniA:5.694p65L-4mniA:5.69 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4n6f | PUTATIVE THIOSUGARSYNTHASE (Amycolatopsisorientalis) |
PF05690(ThiG) | 5 | LEU A 132LEU A 94ALA A 97LEU A 109VAL A 113 | None | 1.09A | 4p65C-4n6fA:undetectable4p65D-4n6fA:undetectable4p65J-4n6fA:undetectable4p65L-4n6fA:undetectable | 4p65C-4n6fA:4.584p65D-4n6fA:7.034p65J-4n6fA:7.034p65L-4n6fA:7.03 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4nph | PROBABLE SECRETIONSYSTEM APPARATUS ATPSYNTHASE SSAN (Salmonellaenterica) |
PF00006(ATP-synt_ab) | 5 | LEU A 230LEU A 254ALA A 251LEU A 249LEU A 325 | None | 0.86A | 4p65C-4nphA:undetectable4p65D-4nphA:undetectable4p65J-4nphA:undetectable4p65L-4nphA:undetectable | 4p65C-4nphA:5.994p65D-4nphA:8.984p65J-4nphA:8.984p65L-4nphA:8.98 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4o89 | RNA 3'-TERMINALPHOSPHATE CYCLASE (Pyrococcushorikoshii) |
PF01137(RTC)PF05189(RTC_insert) | 5 | CYH A 279LEU A 245ALA A 139LEU A 284LEU A 292 | None | 1.12A | 4p65C-4o89A:undetectable4p65D-4o89A:undetectable4p65J-4o89A:undetectable4p65L-4o89A:undetectable | 4p65C-4o89A:8.284p65D-4o89A:7.544p65J-4o89A:7.544p65L-4o89A:7.54 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4ppz | SUCCINYL-DIAMINOPIMELATE DESUCCINYLASE (Neisseriameningitidis) |
PF01546(Peptidase_M20)PF07687(M20_dimer) | 5 | LEU A 216LEU A 213ALA A 212LEU A 277LEU A 252 | None | 0.95A | 4p65C-4ppzA:undetectable4p65D-4ppzA:undetectable4p65J-4ppzA:undetectable4p65L-4ppzA:undetectable | 4p65C-4ppzA:4.924p65D-4ppzA:7.894p65J-4ppzA:7.894p65L-4ppzA:7.89 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4rld | ASPARTIC PROTEASEBLA G 2 (Blattellagermanica) |
PF00026(Asp) | 5 | LEU A 107ALA A 49LEU A 53VAL A 30LEU A 115 | None | 1.03A | 4p65C-4rldA:undetectable4p65D-4rldA:undetectable4p65J-4rldA:undetectable4p65L-4rldA:undetectable | 4p65C-4rldA:5.364p65D-4rldA:9.954p65J-4rldA:9.954p65L-4rldA:9.95 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4rlv | ANKYRIN-1, ANKYRIN-2 (Homo sapiens;Mus musculus) |
PF00023(Ank)PF12796(Ank_2)PF13637(Ank_4)PF13857(Ank_5) | 5 | CYH A2375ALA A2368LEU A2384VAL A2413LEU A2417 | None | 1.16A | 4p65C-4rlvA:undetectable4p65D-4rlvA:undetectable4p65J-4rlvA:undetectable4p65L-4rlvA:undetectable | 4p65C-4rlvA:5.324p65D-4rlvA:4.734p65J-4rlvA:4.734p65L-4rlvA:4.73 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4rlv | ANKYRIN-1, ANKYRIN-2 (Homo sapiens;Mus musculus) |
PF00023(Ank)PF12796(Ank_2)PF13637(Ank_4)PF13857(Ank_5) | 5 | LEU A2171ALA A2195LEU A2211VAL A2248LEU A2252 | None | 1.14A | 4p65C-4rlvA:undetectable4p65D-4rlvA:undetectable4p65J-4rlvA:undetectable4p65L-4rlvA:undetectable | 4p65C-4rlvA:5.324p65D-4rlvA:4.734p65J-4rlvA:4.734p65L-4rlvA:4.73 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4wj7 | MALCAVERNIN (Homo sapiens) |
no annotation | 5 | LEU A 70HIS A 151LEU A 152ALA A 199LEU A 105 | None | 1.16A | 4p65C-4wj7A:undetectable4p65D-4wj7A:undetectable4p65J-4wj7A:undetectable4p65L-4wj7A:undetectable | 4p65C-4wj7A:6.754p65D-4wj7A:14.074p65J-4wj7A:14.074p65L-4wj7A:14.07 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4wja | UNCHARACTERIZEDPROTEIN C9ORF142 (Homo sapiens) |
PF15384(PAXX) | 5 | CYH A 22LEU A 87ALA A 94LEU A 89LEU A 47 | None | 1.04A | 4p65C-4wjaA:undetectable4p65D-4wjaA:undetectable4p65J-4wjaA:undetectable4p65L-4wjaA:undetectable | 4p65C-4wjaA:11.464p65D-4wjaA:11.184p65J-4wjaA:11.184p65L-4wjaA:11.18 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4wjl | INACTIVE DIPEPTIDYLPEPTIDASE 10 (Homo sapiens) |
PF00326(Peptidase_S9)PF00930(DPPIV_N) | 5 | HIS A 741LEU A 742ALA A 745VAL A 707LEU A 708 | None | 0.74A | 4p65C-4wjlA:undetectable4p65D-4wjlA:undetectable4p65J-4wjlA:undetectable4p65L-4wjlA:undetectable | 4p65C-4wjlA:2.794p65D-4wjlA:3.604p65J-4wjlA:3.604p65L-4wjlA:3.60 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4xef | PROTEIN-TYROSINEKINASE 2-BETA20-MER PEPTIDECONTAINING LD1 MOTIFOF LEUPAXIN (Homo sapiens;Homo sapiens) |
PF03623(Focal_AT)no annotation | 5 | LEU A 953HIS A 981LEU A 983ALA A 979LEU B 11 | None | 1.07A | 4p65C-4xefA:undetectable4p65D-4xefA:undetectable4p65J-4xefA:undetectable4p65L-4xefA:undetectable | 4p65C-4xefA:6.474p65D-4xefA:8.634p65J-4xefA:8.634p65L-4xefA:8.63 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4xev | FUSION PROTEIN OFPROTEIN-TYROSINEKINASE 2-BETA FATDOMAIN AND LEUPAXINLD1 MOTIF (Homo sapiens) |
PF03623(Focal_AT) | 5 | LEU A 953HIS A 981LEU A 983ALA A 979LEU A2011 | None | 1.14A | 4p65C-4xevA:undetectable4p65D-4xevA:undetectable4p65J-4xevA:undetectable4p65L-4xevA:undetectable | 4p65C-4xevA:9.284p65D-4xevA:9.264p65J-4xevA:9.264p65L-4xevA:9.26 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4xpz | RNA POLYMERASE IISUBUNIT A C-TERMINALDOMAIN PHOSPHATASE (Schizosaccharomycespombe) |
PF03031(NIF)PF12738(PTCB-BRCT) | 5 | LEU A 429LEU A 434ALA A 455LEU A 504VAL A 495 | None | 1.13A | 4p65C-4xpzA:undetectable4p65D-4xpzA:undetectable4p65J-4xpzA:undetectable4p65L-4xpzA:undetectable | 4p65C-4xpzA:4.354p65D-4xpzA:5.854p65J-4xpzA:5.854p65L-4xpzA:5.85 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4yii | UBIQUITIN-CONJUGATING ENZYME E2 C (Homo sapiens) |
PF00179(UQ_con) | 5 | LEU U 132LEU U 83ALA U 52LEU U 42LEU U 35 | None | 1.02A | 4p65C-4yiiU:undetectable4p65D-4yiiU:undetectable4p65J-4yiiU:undetectable4p65L-4yiiU:undetectable | 4p65C-4yiiU:8.064p65D-4yiiU:11.034p65J-4yiiU:11.034p65L-4yiiU:11.03 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4ysw | XANTHINEDEHYDROGENASE/OXIDASE (Rattusnorvegicus) |
PF00111(Fer2)PF00941(FAD_binding_5)PF01315(Ald_Xan_dh_C)PF01799(Fer2_2)PF02738(Ald_Xan_dh_C2)PF03450(CO_deh_flav_C) | 5 | HIS A 817ALA A 815LEU A 635VAL A 776LEU A 780 | None | 1.11A | 4p65C-4yswA:undetectable4p65D-4yswA:undetectable4p65J-4yswA:undetectable4p65L-4yswA:undetectable | 4p65C-4yswA:1.484p65D-4yswA:2.174p65J-4yswA:2.174p65L-4yswA:2.17 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4yu5 | IMMUNE INHIBITOR A,METALLOPROTEASE (Bacillus cereus) |
PF05547(Peptidase_M6) | 5 | LEU A 169HIS A 275LEU A 274ALA A 277LEU A 241 | None | 1.13A | 4p65C-4yu5A:undetectable4p65D-4yu5A:undetectable4p65J-4yu5A:undetectable4p65L-4yu5A:undetectable | 4p65C-4yu5A:2.584p65D-4yu5A:3.944p65J-4yu5A:3.944p65L-4yu5A:3.94 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5a46 | FIBROBLAST GROWTHFACTOR RECEPTOR 1(FMS-RELATEDTYROSINE KINASE 2,PFEIFFER SYNDROME),ISOFORM CRA_B (Homo sapiens) |
PF07714(Pkinase_Tyr) | 5 | CYH A 603LEU A 569LEU A 573ALA A 626LEU A 689 | None | 1.16A | 4p65C-5a46A:undetectable4p65D-5a46A:undetectable4p65J-5a46A:undetectable4p65L-5a46A:undetectable | 4p65C-5a46A:3.954p65D-5a46A:6.774p65J-5a46A:6.774p65L-5a46A:6.77 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5cb2 | PROTEIN SEY1 (Candidaalbicans) |
PF05879(RHD3) | 5 | LEU A 273LEU A 78VAL A 202HIS A 250LEU A 252 | None | 1.09A | 4p65C-5cb2A:undetectable4p65D-5cb2A:undetectable4p65J-5cb2A:undetectable4p65L-5cb2A:undetectable | 4p65C-5cb2A:4.324p65D-5cb2A:4.014p65J-5cb2A:4.014p65L-5cb2A:4.01 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5ce5 | TRIACYLGLYCEROLLIPASE (Geobacillusthermocatenulatus) |
no annotation | 5 | LEU A 71LEU A 123ALA A 67LEU A 52VAL A 159 | None | 1.10A | 4p65C-5ce5A:undetectable4p65D-5ce5A:undetectable4p65J-5ce5A:undetectable4p65L-5ce5A:undetectable | 4p65C-5ce5A:4.314p65D-5ce5A:7.234p65J-5ce5A:7.234p65L-5ce5A:7.23 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5ckm | MANNAN-BINDINGLECTIN SERINEPEPTIDASE 2 (Rattusnorvegicus) |
PF00431(CUB)PF07645(EGF_CA) | 5 | LEU A 94LEU A 40LEU A 67VAL A 58LEU A 70 | None | 1.03A | 4p65C-5ckmA:undetectable4p65D-5ckmA:undetectable4p65J-5ckmA:undetectable4p65L-5ckmA:undetectable | 4p65C-5ckmA:6.284p65D-5ckmA:6.274p65J-5ckmA:6.274p65L-5ckmA:6.27 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5cof | UNCHARACTERIZEDPROTEIN (Escherichiacoli) |
PF08020(DUF1706) | 5 | LEU A 160ALA A 156LEU A 52VAL A 108LEU A 111 | None | 1.12A | 4p65C-5cofA:undetectable4p65D-5cofA:undetectable4p65J-5cofA:undetectable4p65L-5cofA:undetectable | 4p65C-5cofA:7.694p65D-5cofA:12.774p65J-5cofA:12.774p65L-5cofA:12.77 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5czz | CRISPR-ASSOCIATEDENDONUCLEASE CAS9 (Staphylococcusaureus) |
PF13395(HNH_4)PF16592(Cas9_REC) | 5 | LEU A 183LEU A 109LEU A 100HIS A 191LEU A 76 | None | 1.11A | 4p65C-5czzA:undetectable4p65D-5czzA:undetectable4p65J-5czzA:undetectable4p65L-5czzA:undetectable | 4p65C-5czzA:2.014p65D-5czzA:4.054p65J-5czzA:4.054p65L-5czzA:4.05 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5gvi | UBIQUITINCARBOXYL-TERMINALHYDROLASE 30 (Danio rerio) |
PF00443(UCH) | 5 | LEU A 119LEU A 139ALA A 136LEU A 66LEU A 161 | None | 1.14A | 4p65C-5gviA:undetectable4p65D-5gviA:undetectable4p65J-5gviA:undetectable4p65L-5gviA:undetectable | 4p65C-5gviA:5.174p65D-5gviA:5.744p65J-5gviA:5.744p65L-5gviA:5.74 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5hjr | NEUTRALALPHA-GLUCOSIDASE AB (Mus musculus) |
PF01055(Glyco_hydro_31)PF13802(Gal_mutarotas_2) | 5 | HIS A 477LEU A 475ALA A 479VAL A 431LEU A 432 | None | 1.04A | 4p65C-5hjrA:undetectable4p65D-5hjrA:undetectable4p65J-5hjrA:undetectable4p65L-5hjrA:undetectable | 4p65C-5hjrA:2.594p65D-5hjrA:3.314p65J-5hjrA:3.314p65L-5hjrA:3.31 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5ja1 | ENTEROBACTINSYNTHASE COMPONENT F (Escherichiacoli) |
PF00501(AMP-binding)PF00550(PP-binding)PF00668(Condensation)PF00975(Thioesterase)PF13193(AMP-binding_C) | 5 | LEU A1139LEU A1224ALA A1220VAL A1186LEU A1187 | None | 1.09A | 4p65C-5ja1A:undetectable4p65D-5ja1A:undetectable4p65J-5ja1A:undetectable4p65L-5ja1A:undetectable | 4p65C-5ja1A:1.554p65D-5ja1A:2.384p65J-5ja1A:2.384p65L-5ja1A:2.38 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5jpe | SERINE/THREONINE-PROTEIN PHOSPHATASE (Candidaalbicans) |
PF00149(Metallophos)PF16891(STPPase_N) | 5 | CYH A 456CYH A 336ALA A 331VAL A 226LEU A 253 | None | 1.15A | 4p65C-5jpeA:undetectable4p65D-5jpeA:undetectable4p65J-5jpeA:undetectable4p65L-5jpeA:undetectable | 4p65C-5jpeA:6.164p65D-5jpeA:7.754p65J-5jpeA:7.754p65L-5jpeA:7.75 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5k7f | TRANSCRIPTIONALREGULATOR, TETRFAMILY (Myxococcusxanthus) |
PF00440(TetR_N) | 5 | LEU A 90LEU A 138ALA A 141VAL A 76LEU A 77 | None | 0.88A | 4p65C-5k7fA:undetectable4p65D-5k7fA:undetectable4p65J-5k7fA:undetectable4p65L-5k7fA:undetectable | 4p65C-5k7fA:14.004p65D-5k7fA:9.384p65J-5k7fA:9.384p65L-5k7fA:9.38 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5ool | 39S RIBOSOMALPROTEIN L37,MITOCHONDRIAL (Homo sapiens) |
PF07147(PDCD9) | 5 | LEU 5 198HIS 5 420LEU 5 419ALA 5 422HIS 5 289 | None | 1.05A | 4p65C-5ool5:undetectable4p65D-5ool5:undetectable4p65J-5ool5:undetectable4p65L-5ool5:undetectable | 4p65C-5ool5:4.704p65D-5ool5:6.424p65J-5ool5:6.424p65L-5ool5:6.42 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5t8y | EPOXYQUEUOSINEREDUCTASE (Bacillussubtilis) |
PF08331(DUF1730)PF13484(Fer4_16)PF13646(HEAT_2) | 5 | CYH A 156LEU A 209CYH A 194LEU A 203ALA A 202 | B12 A 503 ( 4.5A)B12 A 503 ( 3.9A)SF4 A 501 (-2.2A)SF4 A 502 ( 4.6A)SF4 A 502 ( 3.9A) | 1.06A | 4p65C-5t8yA:undetectable4p65D-5t8yA:undetectable4p65J-5t8yA:undetectable4p65L-5t8yA:undetectable | 4p65C-5t8yA:3.624p65D-5t8yA:5.664p65J-5t8yA:5.664p65L-5t8yA:5.66 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5u4z | REPRESSOR OF RNAPOLYMERASE IIITRANSCRIPTION (Citrus sinensis) |
PF09174(Maf1) | 5 | LEU A 145LEU A 141ALA A 144LEU A 9LEU A 16 | None | 1.08A | 4p65C-5u4zA:undetectable4p65D-5u4zA:undetectable4p65J-5u4zA:undetectable4p65L-5u4zA:undetectable | 4p65C-5u4zA:5.704p65D-5u4zA:7.944p65J-5u4zA:7.944p65L-5u4zA:7.94 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5ux2 | ALDEHYDEDECARBONYLASE (Synechococcussp. RS9917) |
no annotation | 5 | CYH A 110LEU A 106HIS A 141LEU A 142ALA A 145 | NoneNone FE A 301 (-3.5A)NoneNone | 1.13A | 4p65C-5ux2A:undetectable4p65D-5ux2A:undetectable4p65J-5ux2A:undetectable4p65L-5ux2A:undetectable | 4p65C-5ux2A:undetectable4p65D-5ux2A:undetectable4p65J-5ux2A:undetectable4p65L-5ux2A:undetectable | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5uxb | MACROLIDE2'-PHOSPHOTRANSFERASE MPHH (Brachybacteriumfaecium) |
PF01636(APH) | 5 | LEU A 257HIS A 230LEU A 243VAL A 127LEU A 123 | None | 0.89A | 4p65C-5uxbA:undetectable4p65D-5uxbA:undetectable4p65J-5uxbA:undetectable4p65L-5uxbA:undetectable | 4p65C-5uxbA:8.554p65D-5uxbA:8.644p65J-5uxbA:8.644p65L-5uxbA:8.64 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5vfr | PROTEASOME SUBUNITALPHA TYPE-4 (Homo sapiens) |
no annotation | 5 | LEU I 35LEU I 44ALA I 46LEU I 197LEU I 236 | None | 1.08A | 4p65C-5vfrI:undetectable4p65D-5vfrI:undetectable4p65J-5vfrI:undetectable4p65L-5vfrI:undetectable | 4p65C-5vfrI:undetectable4p65D-5vfrI:undetectable4p65J-5vfrI:undetectable4p65L-5vfrI:undetectable | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5vpq | BETA-LACTAMASE (Paraburkholderiaphymatum) |
PF13354(Beta-lactamase2) | 5 | LEU A 182LEU A 63ALA A 66LEU A 197VAL A 237 | None | 1.11A | 4p65C-5vpqA:undetectable4p65D-5vpqA:undetectable4p65J-5vpqA:undetectable4p65L-5vpqA:undetectable | 4p65C-5vpqA:5.354p65D-5vpqA:6.414p65J-5vpqA:6.414p65L-5vpqA:6.41 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5w19 | TRYPTOPHANASE (Proteusvulgaris) |
no annotation | 5 | LEU A 437LEU A 380ALA A 379LEU A 444VAL A 357 | None | 1.08A | 4p65C-5w19A:undetectable4p65D-5w19A:undetectable4p65J-5w19A:undetectable4p65L-5w19A:undetectable | 4p65C-5w19A:undetectable4p65D-5w19A:undetectable4p65J-5w19A:undetectable4p65L-5w19A:undetectable | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5y4d | ANKYRIN-1,ANKYRIN-2,ANKYRIN-2 (Homo sapiens;Mus musculus) |
PF00023(Ank)PF12796(Ank_2)PF13637(Ank_4) | 5 | LEU A2171ALA A2195LEU A2211VAL A2248LEU A2252 | None | 1.12A | 4p65C-5y4dA:undetectable4p65D-5y4dA:undetectable4p65J-5y4dA:undetectable4p65L-5y4dA:undetectable | 4p65C-5y4dA:4.954p65D-5y4dA:4.264p65J-5y4dA:4.264p65L-5y4dA:4.26 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6cn7 | AEROBACTIN SYNTHASEIUCC (Klebsiellapneumoniae) |
no annotation | 5 | LEU A 548LEU A 21LEU A 78VAL A 84LEU A 41 | None | 1.11A | 4p65C-6cn7A:undetectable4p65D-6cn7A:undetectable4p65J-6cn7A:undetectable4p65L-6cn7A:undetectable | 4p65C-6cn7A:undetectable4p65D-6cn7A:undetectable4p65J-6cn7A:undetectable4p65L-6cn7A:undetectable | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6grw | - (-) |
no annotation | 5 | LEU A 190ALA A 98LEU A 94VAL A 147HIS A 148 | None | 1.14A | 4p65C-6grwA:undetectable4p65D-6grwA:undetectable4p65J-6grwA:undetectable4p65L-6grwA:undetectable | 4p65C-6grwA:undetectable4p65D-6grwA:undetectable4p65J-6grwA:undetectable4p65L-6grwA:undetectable |